Charles Laranjeira
Keine laufenden Positionen mehr
Profil
Charles Anthony Laranjeira worked as the VP-Drug Product Manufacturing at Bristol Myers Squibb Co. from 2009 to 2011.
He then served as the Senior Vice President-Technical Operations at Cubist Pharmaceuticals LLC from 2011 to 2015.
In 2015, he held the position of Vice President-Global Operations at EPIRUS Biopharmaceuticals, Inc. From 2018 to 2023, he worked as the Chief Technical Officer at Pacira Biosciences, Inc. Mr. Laranjeira obtained his undergraduate degree from New Jersey Institute of Technology in 1988.
Ehemalige bekannte Positionen von Charles Laranjeira
| Unternehmen | Position | Ende |
|---|---|---|
| PACIRA BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 01.06.2023 |
| EPIRUS BIOPHARMACEUTICALS, INC. | Chief Operating Officer | 01.05.2016 |
| CUBIST PHARMACEUTICALS INC | Chief Tech/Sci/R&D Officer | 01.04.2015 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01.02.2011 |
Ausbildung von Charles Laranjeira
| New Jersey Institute of Technology | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| PACIRA BIOSCIENCES, INC. | Health Technology |
| EPIRUS BIOPHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Cubist Pharmaceuticals LLC
 Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cubist Pharmaceuticals LLC operates as a biopharmaceutical company. It focuses on the research, development and commercialization of pharmaceutical products. The company was founded in 1992 and is headquartered in Lexington, MA. | Health Technology |
